These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 18023600)

  • 1. Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD.
    Pauwels R; Joos GF; Fogarty C; Faiferman I; Hirschberg S; Vessey R; Wouters EF
    Pulm Pharmacol Ther; 2008; 21(2):385-92. PubMed ID: 18023600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchodilation and safety of supratherapeutic doses of salbutamol or ipratropium bromide added to single dose GSK961081 in patients with moderate to severe COPD.
    Norris V; Ambery C
    Pulm Pharmacol Ther; 2013 Oct; 26(5):574-80. PubMed ID: 23524017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD.
    Singh D; Abbott-Banner K; Bengtsson T; Newman K
    Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30166326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparison of bronchodilating drugs in the treatment of stable COPD].
    Nishimura K; Koyama H; Izumi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):835-43. PubMed ID: 1385837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI.
    Zuwallack R; De Salvo MC; Kaelin T; Bateman ED; Park CS; Abrahams R; Fakih F; Sachs P; Pudi K; Zhao Y; Wood CC;
    Respir Med; 2010 Aug; 104(8):1179-88. PubMed ID: 20172704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.
    Donohue JF; Wise R; Busse WW; Garfinkel S; Zubek VB; Ghafouri M; Manuel RC; Schlenker-Herceg R; Bleecker ER
    BMC Pulm Med; 2016 Apr; 16(1):65. PubMed ID: 27130202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover study.
    Singh D; Zhu CQ; Sharma S; Church A; Kalberg CJ
    Pulm Pharmacol Ther; 2015 Apr; 31():85-91. PubMed ID: 25197005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Chest; 1995 Feb; 107(2):401-5. PubMed ID: 7842768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
    Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.
    Brophy C; Kastelik J; Gardiner E; Greenstone M
    Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formoterol: a review of its use in chronic obstructive pulmonary disease.
    Cheer SM; Scott LJ
    Am J Respir Med; 2002; 1(4):285-300. PubMed ID: 14720051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does a single dose of the phosphodiesterase 4 inhibitor, cilomilast (15 mg), induce bronchodilation in patients with chronic obstructive pulmonary disease?
    Grootendorst DC; Gauw SA; Baan R; Kelly J; Murdoch RD; Sterk PJ; Rabe KF
    Pulm Pharmacol Ther; 2003; 16(2):115-20. PubMed ID: 12670781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R; Make B
    COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies.
    Quinn D; Barnes CN; Yates W; Bourdet DL; Moran EJ; Potgieter P; Nicholls A; Haumann B; Singh D
    Pulm Pharmacol Ther; 2018 Feb; 48():71-79. PubMed ID: 28987804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of the combination of inhaled ipratropium and oral theophylline in asthma.
    Burki NK
    Chest; 1997 Jun; 111(6):1509-13. PubMed ID: 9187165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
    Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of salbutamol and ipratropium bromide on arterial blood gases in patients with stable COPD].
    Ozdemir T; Geçkin E; Oğüş C; Cilli A
    Tuberk Toraks; 2003; 51(2):132-7. PubMed ID: 15143418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled formoterol versus ipratropium bromide in chronic obstructive pulmonary disease.
    Chhabra SK; Vijayan VK; Vasu T
    Indian J Chest Dis Allied Sci; 2006; 48(2):97-102. PubMed ID: 16696522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.